Skip to main content

Table 3 Althered expression of circRNA associated with clinicopathological features from various tumor patients

From: CircRNAs as biomarkers of cancer: a meta-analysis

Clinicopathological factors

Altered expression of circRNA

Up

Down

TNM stage

hsa_circ_0013958

circZKSCAN1, hsa_circ_0004018, hsa_circ_002059, hsa_circ_0000190, hsa_circ_0003159, hsa_circ_001471a, hsa_circ_0000096

Differentitation

hsa_circ_0004018, hsa_circ_001988, hsa_circ_0001895, hsa_circ_0003570 hsa_circ_00001649,

Tumor size (Diameter < 5 cm)

hsa_circ_0005075

hsa_circ_0004018, hsa_circ_0001649, hsa_circ_0000190, hsa_circ_0003570

Tumor number

circZKSCAN1

Distal metastasis

circZKSCAN1b, hsa_circ_002059, hsa_circ_0000190, hsa_circ_0003159, hsa_circ_0014717, hsa_circ_0000096, hsa_circ_0006633

Lymphatic metastasis

hsa_circ_0013958

hsa_circ_0000190,

MVI

circZKSCAN1, hsa_circ_0003570

Age

hsa_circ_002059

Gender

hsa_circ_002059, hsa_circ_0003159, hsa_circ_0000096

CEA

hsa_circ_0014717, hsa_circ_0001895, hsa_circ_0006633

CA19–9

hsa_circ_0000190, hsa_circ_0014717

PNI

hsa_circ_001988

  1. MVI Microscopic vascular invasion CEA Carcinoembryonic antigen(tissue), PNI Perineural invasion, CA19–9 Carbohydrate antigen 19–9
  2. aEarly and advanced grade, b Vascular invasion